Bank Of New York Mellon Corp Aim Immuno Tech Inc. Transaction History

Bank Of New York Mellon Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$0.32 - $0.77 $8,085 - $19,456	25,268 New	25,268 $10.9 Million
Q4 2022 Feb 14, 2023	BUY	$0.31 - $0.6 $7,833 - $15,160	25,268 New	25,268 $7,000
Q2 2022 Aug 15, 2022	SELL	$0.78 - $1.27 $1,791 - $2,917	-2,297 Reduced 8.33%	25,268 $20,000
Q3 2021 Nov 12, 2021	BUY	$1.91 - $2.17 $4,387 - $4,984	2,297 Added 9.09%	27,565 $56,000
Q1 2021 May 13, 2021	SELL	$1.88 - $2.82 $5,143 - $7,715	-2,736 Reduced 9.77%	25,268 $57,000
Q3 2020 Nov 12, 2020	BUY	$1.77 - $3.88 $49,567 - $108,655	28,004 New	28,004 $60,000

9.04M

Ticker AIM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,049,300
Market Cap $10.1M
Description
AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's products include Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.